Year All 2026 2025 2024 2023 Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026 October 15, 2026 Read More Caris Life Sciences to Present Eight Studies Highlighting the Power of AI, Multi-Omics and Precision Medicine at ESMO 2026 October 14, 2026 Read More Caris Life Sciences Launches New National Commercial Featuring Kevin Costner to Raise Awareness of Early Cancer Detection and Caris Detect September 8, 2026 Read More Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer September 2, 2026 Read More Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer August 27, 2026 Read More Caris Life Sciences Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance August 5, 2026 Read More Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026 July 16, 2026 Read More Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing July 14, 2026 Read More Caris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood Test July 1, 2026 Read More Caris Life Sciences Announces Dual Listing on NYSE Texas June 16, 2026 Read More
Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026 October 15, 2026 Read More
Caris Life Sciences to Present Eight Studies Highlighting the Power of AI, Multi-Omics and Precision Medicine at ESMO 2026 October 14, 2026 Read More
Caris Life Sciences Launches New National Commercial Featuring Kevin Costner to Raise Awareness of Early Cancer Detection and Caris Detect September 8, 2026 Read More
Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer September 2, 2026 Read More
Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer August 27, 2026 Read More
Caris Life Sciences Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance August 5, 2026 Read More
Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026 July 16, 2026 Read More
Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing July 14, 2026 Read More
Caris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood Test July 1, 2026 Read More
